Patents Assigned to PHOSPHAGENICS LIMITED
  • Pharmaceutical formulation
    Patent number: 10973761
    Abstract: The present invention relates to a formulation comprising a primary surfactant, a tocol phosphate, water, an active agent, and optionally an oil, wherein the active agent and/or the optional oil comprises a hydrophobic phase.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: April 13, 2021
    Assignee: Phosphagenics Limited
    Inventor: Mahmoud El-Tamimy
  • Composition
    Patent number: 10188670
    Abstract: Compositions and formulations comprising a non-neutralized tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: January 29, 2019
    Assignee: Phosphagenics Limited
    Inventor: Roksan Libinaki
  • Carrier comprising non-neutralised tocopheryl phosphate
    Patent number: 10071030
    Abstract: The present invention relates to a carrier for the delivery of a nutraceutical or cosmeceutical active comprising non-neutralized tocopheryl phosphate and a hydrophobic vehicle. The present invention also relates to a formulation comprising the carrier and a nutraceutical or cosmeceutical active.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: September 11, 2018
    Assignee: Phosphagenics Limited
    Inventor: Roksan Libinaki
  • Composition comprising non-neutralised tocol phosphate and a vitamin A compound
    Patent number: 9561243
    Abstract: Compositions and formulations comprising a non-neutralized tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: February 7, 2017
    Assignee: Phosphagenics Limited
    Inventor: Roksan Libinaki
  • Transdermal delivery patch
    Patent number: 9314527
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: April 19, 2016
    Assignee: Phosphagenics Limited
    Inventors: Jeremy Cottrell, Giacinto Gaetano, Mahmoud El-Tamimy, Nicholas Kennedy, Paul David Gavin
  • COMPOSITION
    Publication number: 20140255509
    Abstract: Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 11, 2014
    Applicant: PHOSPHAGENICS LIMITED
    Inventors: Roksan Libinaki, Robert Lee Neely
  • TRANSDERMAL DELIVERY PATCH
    Publication number: 20140155495
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Application
    Filed: November 21, 2013
    Publication date: June 5, 2014
    Applicant: PHOSPHAGENICS LIMITED
    Inventors: Jeremy Cottrell, Giacinto Gaetano, Mahmoud El-Tamimy, Nicholas Kennedy, Paul David Gavin
  • Transdermal delivery patch
    Patent number: 8652511
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: February 18, 2014
    Assignee: Phosphagenics Limited
    Inventors: Jeremy Cottrell, Giacinto Gaetano, Mahmoud El-Tamimy, Nicholas Kennedy, Paul David Gavin
  • TRANSDERMAL DELIVERY PATCH
    Publication number: 20130101660
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of an opioid, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Application
    Filed: November 21, 2012
    Publication date: April 25, 2013
    Applicant: PHOSPHAGENICS LIMITED
    Inventor: PHOSPHAGENICS LIMITED
  • TRANSDERMAL DELIVERY PATCH
    Publication number: 20110244022
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of an opioid, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Application
    Filed: May 18, 2010
    Publication date: October 6, 2011
    Applicant: PHOSPHAGENICS LIMITED
    Inventors: Jeremy Cottrell, Giacinto Gaetano, Mahmoud El-Tamimy, Nicholas Kennedy, Paul David Gavin
  • TRANSDERMAL DELIVERY PATCH
    Publication number: 20110244023
    Abstract: A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer carrier.
    Type: Application
    Filed: May 18, 2010
    Publication date: October 6, 2011
    Applicant: PHOSPHAGENICS LIMITED
    Inventors: Jeremy Cottrell, Giacinto Gaetano, Mahmoud El-Tamimy, Nicholas Kennedy, Paul David Gavin